Peng Lü

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial

Hermine I. Brunner, Nicolino Ruperto, Zbigniew Żuber et al. · Annals of the Rheumatic Diseases · 2014 · 296 citations · Full text

A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study)

Gerd R Burmester, Andrea Rubbert‐Roth, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 2013 · 237 citations · Full text

Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA

Hisham Abdallah, Joy Hsu, Peng Lü et al. · The Journal of Clinical Pharmacology · 2016 · 94 citations · Full text

Immunology, Pharmacotherapy, Immunotherapy +16

Combined effect of konjac glucomannan addition and ultrasound treatment on the physical and physicochemical properties of frozen dough

Peng Lü, Jinying Guo, Jiawei Fan et al. · Food Chemistry · 2023 · 83 citations

Food Chemistry, Konjac Glucomannan Addition, Functional Property +6

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study

William R. Lumry, Karsten Weller, Markus Magerl et al. · Allergy · 2020 · 56 citations · Full text